Article Versions Notes

Schwengber WK, Silveira VB, Hetzel GM, Robaina A, Ceolin L, Camelier MT, Goemann I, Dalla Corte RR, Scheffel RS, de Mello RGB, et al. Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study. Metabolites. 2022; 12(5):375. https://doi.org/10.3390/metabo12050375

Schwengber, Wallace Klein, Vitor Bock Silveira, Guilherme Moreira Hetzel, Amanda Robaina, Lucieli Ceolin, Marli Teresinha Camelier, Iuri Goemann, Roberta Rigo Dalla Corte, Rafael Selbach Scheffel, Renato Gorga Bandeira de Mello, and et al. 2022. "Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study" Metabolites 12, no. 5: 375. https://doi.org/10.3390/metabo12050375

Schwengber, W. K., Silveira, V. B., Hetzel, G. M., Robaina, A., Ceolin, L., Camelier, M. T., Goemann, I., Dalla Corte, R. R., Scheffel, R. S., de Mello, R. G. B., Maia, A. L., & Dora, J. M. (2022). Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study. Metabolites, 12(5), 375. https://doi.org/10.3390/metabo12050375